Wenlong Feng - Publications

Inhibition of CDK9 sensitizes multidrug resistant ovarian cancer cells to paclitaxel.

Journal: Scientific reports

Published: December 11, 2025

Multicenter study of ovarian cancer score for diagnosing ovarian cancer.

Journal: Gynecologic oncology

Published: October 20, 2024

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.

Journal: Therapeutic advances in medical oncology

Published: June 13, 2020

Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: May 08, 2020

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma.

Journal: Therapeutic advances in medical oncology

Published: November 18, 2019

Discovery of a Novel Benzenesulfonamide Analogue That Inhibits Proliferation and Metastasis Against Ovarian Cancer OVCAR-8 Cells.

Journal: Drug design, development and therapy

Published: July 29, 2019

Exosomes promote pre-metastatic niche formation in ovarian cancer.

Journal: Molecular cancer

Published: June 01, 2019

PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.

Journal: Life sciences

Published: May 08, 2019